News

A 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.

Angelo Landriscina, MD, FAAD, discusses how to care for your LGBTQ+ patients while also effectively addressing their different dermatologic needs.

With up to 30% of pediatric health care visits involving skin complaints and fewer than 400 board-certified pediatric dermatologists in the United States, teledermatology offers a valuable tool for increasing access and cutting wait times.

This is the first overhaul in a quarter century that simplifies evaluation and management and increases flexibility.

CDC advises not to delay shingles vaccination.

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis diagnosis, treating eczema on darker skin types, the efficacy of pore vacuums, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes articles on the oral, narrow-spectrum antibiotics for acne, the best practices for atopic dermatitis care, oxytocin and its effect on skin aging, plus more.

In this video interview with Dermatology Times, one expert discusses how narrow-spectrum antibiotics can both protect the skin and gut microbiome, as well as effectively treat acne.

Watch one expert detail the benefits and limitations when using oral antibiotics for the treatment of acne.

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis medication, “slugging” to treat cystic acne, chemical peels for darker skin types, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes articles on the multiple modalities to revise scars, the future of dermatology, phase 3 results of tapinarof cream for plaque psoriasis, guidelines for the COVID-19 vaccine and dermal fillers, plus more.

ASDSA has issued a patient safety alert after videos surface online of children/teens self-injecting HA via “hyaluron pens”.

Joel Cohen, MD, gives a synopsis of a panel discussion he was recently a part of at the 2021 ODAC Dermatology, Aesthetic and Surgical Conference focusing on the postoperative treatment of scars using a variety of methods including lasers, filler and other modalities.

In this episode, Gary Salman, CEO of Black Talon Security, details how to best protect your practice from data breaches and cybercriminals, as well as the risks of not implementing cybersecurity measures into your practice and what to do if a data or email breach occurs.

Three experts chart game-changing innovations that will shift the boundaries of dermatology.

Treatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.

This week’s edition of The Mainstream Patient features stories on hidradenitis suppurativa, the rise of contact dermatitis, sebaceous filaments, coconut oil for the face, plus more.

A glimpse at what to expect from Dermatology Times this week.

In case you missed it, some of this week’s featured content includes the latest FDA approvals, newly published phase 3 data for tirbanibulin, oxytocin and its effect on skin aging, plus more.

Nicole Hayre, MD, FAAD, discusses her recent research related to oxytocin's effect on skin aging and how increased levels of oxytocin in the body can make the skin appear younger.

Topical probiotics show promise in treating various skin diseases including acne, but more research is needed.

Spending time around animals as an infant has been suggested as a way to reduce the incidence of atopic dermatitis. An investigation offers some insight.

The FDA has approved cemiplimab-rwlc as the first immunotherapy for use in patients with advanced basal cell carcinoma that has previously been treated with a hedgehog pathway inhibitor (HHI) or for whom a HHI is not appropriate.

According to one expert, recently completed phase 3 trials of novel drugs have shown impressive results, with 2021 expected to be an exciting year that will bring further advances in treatment options for patients with moderate-to-severe plaque psoriasis.

This week’s edition of The Mainstream Patient features stories on tretinoin, dermal fillers, dermarolling, niacinamide, and more.

A glimpse at what to expect from Dermatology Times this week.

In case you missed it, some of this week’s featured content includes a new podcast episode on the popularity of TikTok for dermatologists, FDA approvals for Soliton’s RAP device for cellulite and Galderma’s Restylane Defyne for chin augmentation, enrollment commencement for a food supplement and skin inflammation study, plus more.

In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, shares her tips for using cosmetics under face masks.